QA: GlobeStar Therapeutics Corp in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001502152_2020_GlobeStar_Therapeutics_Corp.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001502152')"}
info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001502152, GlobeStar Therapeutics Corp

  xvar xval
0 AssetsCurrent 141,361
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 822
3 remainder_Assets 0
4 LiabilitiesCurrent 827,618
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 154
8 SellingGeneralAndAdministrativeExpense 316,141
9 ResearchAndDevelopmentExpense 0
10 remainder_Expenses 360,363
11 remainder_Revenues 425
12 remainder_NetIncome 1,161
13 remainder_ComprehensiveNetIncome -971
  yvar yval
0 Assets 142,183
1 Liabilities 827,618
2 Expenses 676,658
3 Revenues 425
4 StockholdersEquity -685,435
5 NetIncome -675,072
6 ComprehensiveNetIncome -675,558
7 BaseVar 824,508
8 EconomicCapitalRatio -3.82

Edgar->Model Mapping

Feature Distribution

Change over Time